CLIMB BIO INC. - COMMON STOCK

Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Host Virtual Investor Event Featuring Opinion Leaders in Chronic Pain Research on February 16, 2022

07 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones

18 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

08 ноя 2021 16:01:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics to Participate at Four Upcoming Investor Conferences

04 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial Results

13 сен 2021 16:10:00 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

12 авг 2021 21:06:11 Источник Nasdaq GlobeNewswire

Eliem Therapeutics Announces Pricing of Initial Public Offering

09 авг 2021 22:33:09 Источник Nasdaq GlobeNewswire